| Literature DB >> 36253846 |
Amirhossein Parsaei1, Aida Mehdipour2, Hamidreza Ghadimi3, Ashkan Mohammadi Kooshki4, Parisa Shajari5, Maryam Masoumi6, Pouya Torabi1, Hossein Azizi1, Behnam Amini1, Hanie Karimi1, Hojat Dehghanbanadaki7, Mohammad Aghaali8, Soroush Moradi1.
Abstract
BACKGROUND: Compared to the healthy population, the psychological impact of rheumatoid arthritis(RA) on patients' lives could dramatically lower their oral health-related quality of life (OHRQoL). Our goal is to analyze OHRQoL in RA patients and look into the role of disease activity, dental health index, and Temporomandibular disorders score in maintaining their oral health.Entities:
Keywords: DAS28; OHIP-14; OHRQol; Oral health; Rheumatoid arthritis; Rheumatology
Year: 2022 PMID: 36253846 PMCID: PMC9578249 DOI: 10.1186/s41927-022-00292-w
Source DB: PubMed Journal: BMC Rheumatol ISSN: 2520-1026
Demographic and medical characteristics of Participants
| Controls N = 40 | RA patients N = 40 | ||
|---|---|---|---|
| Age (years), Mean ± SD | 53.3 ± 8.2 | 53.7 ± 7.8 | 0.824 |
| Female | 34 (85) | 34 (85) | – |
| Male | 6 (15) | 6 (15) | |
| Not married | 1 (2.5) | 2 (5) | 1.000 |
| Married | 39 (97.5) | 38 (95) | |
| Middle school or lower | 32 (80) | 27 (67.5) | 0.151 |
| Secondary school | 3 (7.5) | 8 (20) | |
| Diploma | 3 (7.5) | 1 (2.5) | |
| Bachelor's degree | 1 (2.5) | 4 (10) | |
| Master's degree | 0 | 0 | |
| Doctorate or higher | 1 (2.5) | 0 | |
| Housewife/unemployed | 30 (75) | 30 (75) | 0.514 |
| Full-time employee | 4 (10) | 1 (2.5) | |
| Self-employed | 4 (10) | 5 (12.5) | |
| Retired | 2 (5) | 4 (10) | |
| Prednisolone | 39 (97.5) | – | |
| Methotrexate | 31 (77.5) | ||
| Hydroxychloroquine | 22 (55) | ||
| Leflunomide | 9 (22.5) | ||
| Sulfasalazine | 3 (7.5) | ||
| Adalimumab | 3 (7.5) | ||
| Methylprednisolone acetate | 2 (5) | ||
| Etanercept | 2 (5) | ||
| Prednisolone dose (mg/day), Mean ± SD | 5.7 ± 2.2 | – | |
| Positive Anti-citrullinated protein antibody, N(%) | 13 (65) | – | |
| Smoking, N(%) | 4 (10) | 6 (15) | 0.749 |
| Disease duration (years), Mean ± SD | 5.7 ± 6.3 | – | |
| Positive rheumatoid factor, N(%) | 4 (10) | – | |
| Remission (DAS28 < 2.6) | 15 (37.5) | – | |
| Low (2.6 ≤ DAS28 < 3.2) | 7 (17.5) | ||
| Moderate (3.2 ≤ DAS28 ≤ 5.1) | 12 (30) | ||
| High(5.1 < DAS28) | 6 (15) | ||
*Fischer's exact or independent samples t-test as appropriate
Comparison of Oral Health Impact Profile scores between RA patients and healthy controls(left), and assessment of the association of each item with RA activity(right)
| OHIP-14 dimensions/questions | Mann–Whitney U test | Kruskal–Wallis test | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study groups, mean ± SD | RA activity, mean rank | Significance | ||||||||
| Control(N = 40) | RA patients(N = 40) | Total(80 N) | Z-score | Significance | Remission | Low Disease Activity | Moderate Disease Activity | Severe Disease Activity | ||
| Trouble pronouncing words | 0.08 ± 0.35 | 0.42 ± 0.93 | 0.25(0.72 | −2.275 | .023* | 19.93 | 16.00 | 24.63 | 18.92 | 0.170 |
| Sense of taste worsened | 0.43 ± 0.74 | 1.25 ± 1.37 | 0.84 ± 1.17 | −2.954 | .003* | 19.97 | 19.00 | 21.67 | 21.25 | 0.956 |
| Painful aching in mouth | 0.90 ± 0.92 | 1.33 ± 1.24 | 1.11 ± 1.11 | −1.415 | 0.157 | 19.87 | 16.29 | 24.13 | 19.75 | 0.507 |
| Uncomfortable eating | 0.35 ± 0.77 | 1.33 ± 1.45 | 0.84 ± 1.25 | −3.331 | 0.001* | 23.33 | 17.36 | 22.63 | 12.83 | 0.171 |
| Felt self-conscious | 0.50(0.96 | 1.15 ± 1.36 | 0.83 ± 1.22 | −2.367 | 0.018* | 22.83 | 18.64 | 22.08 | 13.67 | 0.314 |
| Felt tense | 0.30 ± 0.79 | 1.00 ± 1.39 | 0.65 ± 1.18 | −2.750 | 0.006* | 21.97 | 20.71 | 21.63 | 14.33 | 0.474 |
| Diet unsatisfactory | 0.20 ± 0.56 | 0.78 ± 1.25 | 0.49 ± 1.00 | −2.313 | 0.021* | 21.33 | 22.57 | 19.96 | 17.08 | 0.750 |
| Interrupt meals | 0.37 ± 0.62 | 0.70 ± 1.06 | 0.54 ± 0.88 | −1.300 | 0.194 | 20.53 | 21.29 | 21.42 | 17.67 | 0.901 |
| Difficulty relaxing | 0.27 ± 0.64 | 1.00 ± 1.377 | 0.64 ± 1.12 | −2.776 | 0.006* | 22.70 | 23.93 | 20.25 | 11.50 | 0.128 |
| Been embarrassed | 0.30 ± 0.68 | 1.08 ± 1.52 | 0.69 ± 1.23 | −2.336 | 0.019* | 19.83 | 23.00 | 23.88 | 12.50 | 0.147 |
| Irritable with other people | 0.38 ± 0.58 | 0.80 ± 1.32 | 0.59 ± 1.04 | −.674 | 0.501 | 21.23 | 19.79 | 20.46 | 19.58 | 0.981 |
| Difficulty doing usual jobs | 0.18 ± 0.44 | 0.63 ± 1.17 | 0.40 ± 0.90 | −1.623 | 0.105 | 22.37 | 21.00 | 19.29 | 17.67 | 0.701 |
| Life less satisfying | 0.10 ± 0.37 | 0.75 ± 1.29 | 0.43 ± 1.00 | −2.874 | 0.004* | 21.13 | 20.29 | 23.08 | 14.00 | 0.307 |
| Unable to function | 0.15 ± 0.36 | 0.58 ± 1.15 | 0.36 ± 0.87 | −1.393 | 0.164 | 21.30 | 21.43 | 20.08 | 18.25 | 0.894 |
| Total Oral Function | 1.42 ± 2.17 | 4.47 ± 4.49 | 2.95 ± 3.82 | −3.592 | < 0.001* | 20.93 | 19.86 | 22.42 | 16.33 | 0.766 |
| Total Psychosocial Impact | 1.67 ± 2.30 | 5.82 ± 8.06 | 3.75 ± 6.25 | −1.709 | 0.087 | 20.20 | 23.00 | 23.25 | 20.20 | 0.286 |
| OHIP-14 sum score | 4.50 ± 5.49 | 12.78 ± 14.04 | 8.64 ± 11.38 | −3.186 | 0.001* | 20.60 | 19.57 | 23.21 | 15.92 | 0.655 |
| OHIP-14 Extent score | 0.30 ± 0.88 | 1.98 ± 3.48 | 1.14 ± 2.66 | −2.874 | 0.004* | 20.97 | 23.07 | 21.21 | 14.92 | 0.518 |
*Statistically significant difference (P-value < 0.05)
Comparison of temporomandibular joint disorder and DMFT between RA patients and healthy controls(left), and assessment of the association of each item with RA activity(right)
| Items | Mann–Whitney U | Kruskal–Wallis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study groups | RA activity | |||||||||
| Control(40 N) | RA patients(40 N) | Total(80 N) | Z-score | Significance | Remission | Low Disease Activity | Moderate Disease Activity | Severe Disease Activity | Significance | |
| TMD sum score | 2.05 ± 1.89 | 6.67 ± 7.59 | 4.36 ± 5.97 | −4.433 | < 0.001 | 19.03 | 19.21 | 24.71 | 17.25 | .500 |
| Decayed Teeth | 2.00 ± 1.93 | 3.95 ± 3.95 | 2.97 ± 3.24 | −1.852 | .064 | 19.13 | 18.79 | 22.58 | 21.75 | .842 |
| Missed Teeth | 5.07 ± 5.53 | 9.60 ± 8.98 | 7.34 ± 7.34 | −2.420 | .016* | 22.30 | 18.43 | 17.88 | 23.67 | .652 |
| Filled Teeth | 3.45 ± 3.85 | 3.80 ± 4.83 | 3.63 ± 4.34 | −.304 | .761 | 21.97 | 17.71 | 21.33 | 18.42 | .817 |
*Statistically significant difference (P-value < 0.05)
Correlation between clinical and medical variables and disease activity in RA patients, with and without adjustment for DMFT
| Variables | Spearman’s correlation | |
|---|---|---|
| No adjustment | After adjustment for DMFT | |
| DAS-28 score | DAS-28 score | |
| Coefficient | 0.373* | 0.241* |
| Significance | 0.001 | 0.033 |
| Coefficient | 0.160 | 0.091 |
| Significance | 0.158 | 0.429 |
| Coefficient | 0.330* | 0.149 |
| Significance | 0.003 | 10.192 |
| Coefficient | 0.263* | 0.103 |
| Significance | 0.018 | 0.370 |
| Coefficient | 0.477* | 0.246* |
| Significance | < 0.001 | 0.030 |
| Coefficient | 0.239* | – |
| Significance | 0.033 | – |
| Coefficient | 0.245* | – |
| Significance | 0.028 | – |
| Coefficient | −0.056 | – |
| Significance | 0.622 | – |
*Significant correlation by Spearman's test, P-value < 0.05